Psyence Biomedical Ltd.
PBMWW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001985062
No open-market purchases or sales by Psyence Biomedical Ltd. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $121.6K in total; no superinvestor holds it.
Other share classesPBM
13F holders, Q1 2024
Institutional positions in Psyence Biomedical Ltd. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- +30 vs. Q4 2023
- Shares held
- 6.76M
- +6.76M vs. Q4 2023
- Total value
- $499.9K
- +$499.9K vs. Q4 2023
- New holders
- 30
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PBMWW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $121.6K |
| Q1 2026 | 19 | $96.6K |
| Q4 2025 | 21 | $101.1K |
| Q3 2025 | 23 | $142.4K |
| Q2 2025 | 23 | $123.8K |
| Q1 2025 | 23 | $96.4K |
| Q4 2024 | 22 | $80.2K |
| Q3 2024 | 23 | $79.2K |
| Q2 2024 | 28 | $71.9K |
| Q1 2024 | 30 | $499.9K |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Psyence Biomedical Ltd.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| EHP Funds Inc. | 1,232,748 | $86.3K | 0.06% | +1,232,748 | New |
| Cantor Fitzgerald, L. P. | 468,500 | $59.9K | 0.01% | +468,500 | New |
| Polar Asset Management Partners Inc. | 733,000 | $51.3K | 0.00% | +733,000 | New |
| MMCAP International Inc. SPC | 600,000 | $42.0K | 0.01% | +600,000 | New |
| Calamos Advisors LLC | 500,000 | $35.8K | 0.00% | +500,000 | New |
| Saba Capital Management, L.P. | 297,847 | $21.3K | 0.00% | +297,847 | New |
| Periscope Capital Inc. | 300,000 | $21.0K | 0.01% | +300,000 | New |
| Aristeia Capital LLC | 272,857 | $19.5K | 0.00% | +272,857 | New |
| Clear Street Derivatives LLC | 277,919 | $19.5K | 0.00% | +277,919 | New |
| Context Capital Management, LLC | 234,200 | $16.4K | 0.00% | +234,200 | New |
| LMR Partners LLP | 200,000 | $14.0K | 0.00% | +200,000 | New |
| Walleye Capital LLC | 198,296 | $13.9K | 0.00% | +198,296 | New |
| Clear Street LLC | 180,276 | $12.6K | 0.00% | +180,276 | New |
| D. E. Shaw & Co., Inc. | 175,352 | $12.6K | 0.00% | +175,352 | New |
| Shaolin Capital Management LLC | 175,000 | $12.2K | 0.00% | +175,000 | New |
| Tenor Capital Management Co., L.P. | 150,000 | $10.5K | 0.00% | +150,000 | New |
| Wolverine Asset Management LLC | 134,917 | $9.44K | 0.00% | +134,917 | New |
| Cowen and Company, LLC | 130,287 | $9.12K | 0.00% | +130,287 | New |
| Westchester Capital Management, LLC | 92,073 | $6.59K | 0.00% | +92,073 | New |
| Yakira Capital Management, Inc. | 76,843 | $5.38K | 0.00% | +76,843 | New |
| Mizuho Securities USA LLC | 89,325 | $4.47K | 0.00% | +89,325 | New |
| Mint Tower Capital Management B.V. | 50,000 | $4.00K | 0.00% | +50,000 | New |
| Flow State Investments, L.P. | 55,000 | $3.85K | 0.00% | +55,000 | New |
| Whitebox Advisors LLC | 50,000 | $3.50K | 0.00% | +50,000 | New |
| Walleye Trading LLC | 24,354 | $1.71K | 0.00% | +24,354 | New |
| Schonfeld Strategic Advisors LLC | 24,300 | $1.70K | 0.00% | +24,300 | New |
| SkyView Investment Advisors, LLC | 17,500 | $1.00K | 0.00% | +17,500 | New |
| Ancora Advisors, LLC | 5,000 | $350 | 0.00% | +5,000 | New |
| UBS Group AG | 73 | $5 | 0.00% | +73 | New |
| Anson Funds Management LP | 12,500 | – | – | +12,500 | New |